Research Area 005: Advanced Development of Diagnostics for Biothreats and Emerging Infectious Diseases
- Supports advancing the development of novel, rapid sample-to-answer candidate diagnostic products that will address biodefense and pandemic preparedness.
- Number of Awards/Total Costs: NIAID estimates that one or more awards may be issued for this Research Area for a total cost of up to $2 million for the non-severable base work across all contracts (direct and indirect costs combined).
- Due Date: April 9, 2020, by 3 p.m. Eastern Time
Learn more about this BAA in Funding News.
Global Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.